The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
The course Software Specific Challenges is a must for every TTO/KTO professional, especially for those working with Social Sciences and Humanities!
Brechtje Vreenegoor
Radboud University, Netherlands
Just perfect 3 days full of information and perfect communication.
Petr Kubečka
Palacký University Olomouc, Czech Republic
I strongly recommend the course, even if you are not going to set-up an office but you are part of the team that wants to change or improve how technology transfer is done at your institution.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Most experienced technology transfer crew in the Europe.
Krzysztof Maternicki
Jan Dlugosz University, Poland
Join our newsletter and get the latest news